Hacker News
- Controversial Alzheimer’s drug could cost US $334B–nearly half of DoD budget https://arstechnica.com/science/2021/06/controversial-alzheimers-drug-could-cost-us-334b-nearly-half-of-dod-budget/ 9 comments
- Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget - Despite unproven efficacy, Biogen set the drug’s list price at $56,000 per year. https://arstechnica.com/science/2021/06/controversial-alzheimers-drug-could-cost-us-334b-nearly-half-of-dod-budget/ 8 comments politics
Linking pages
- Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever | Ars Technica https://arstechnica.com/science/2021/11/dubious-56000-alzheimers-drug-spurs-largest-medicare-price-hike-ever/ 100 comments
- AT&T gives investors and gov’t wildly different takes on need for fiber Internet | Ars Technica https://arstechnica.com/tech-policy/2021/06/att-says-fiber-is-superior-even-as-it-lobbies-against-nationwide-build-out/ 89 comments
- Physicists confirm two cases of “elusive” black hole/neutron star mergers | Ars Technica https://arstechnica.com/science/2021/06/physicists-confirm-two-cases-of-elusive-black-hole-neutron-star-mergers/ 57 comments
Linked pages
- AT&T gives investors and gov’t wildly different takes on need for fiber Internet | Ars Technica https://arstechnica.com/tech-policy/2021/06/att-says-fiber-is-superior-even-as-it-lobbies-against-nationwide-build-out/ 89 comments
- Physicists confirm two cases of “elusive” black hole/neutron star mergers | Ars Technica https://arstechnica.com/science/2021/06/physicists-confirm-two-cases-of-elusive-black-hole-neutron-star-mergers/ 57 comments
- FDA officials asked to step down after contentious Alzheimer’s drug approval | Ars Technica https://arstechnica.com/science/2021/06/advocacy-org-calls-for-ouster-of-fda-officials-after-alzheimers-drug-approval/ 4 comments
- A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug | Ars Technica https://arstechnica.com/science/2021/06/a-disgraceful-decision-researchers-blast-fda-for-approving-alzheimers-drug/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget | Ars Technica
See how to search.